Achieving the U.S. goal of reducing new HIV infections by 90% over 10 years will require accelerated efforts to diagnose, treat and prevent HIV, according to a new report from the Centers for Disease Control and Prevention. About 86% of the estimated 1.2 million Americans living with HIV in 2017 had received a laboratory-confirmed diagnosis and 63% of those diagnosed with HIV had the virus under control through effective treatment, the report notes. In 2018, about 18% of the estimated 1.2 million Americans who could benefit from preexposure prophylaxis (PrEP) received a prescription for the medication. The Department of Health and Human Services today launched a national program to make PrEP available at no cost to people without prescription drug insurance coverage. The number of new HIV infections remained relatively stable between 2013 and 2017 at about 38,000 per year. “The time is now to end HIV in America,” said CDC Director Robert Redfield, M.D. “We have the right tools, the right data and the right leadership to get this done.” In February, the administration proposed a national initiative to reduce new HIV infections by at least 90% by 2030 through testing, treatment and PrEP.

 

Related News Articles

Headline
A total of 2,291 patients have been hospitalized for vaping-associated lung injuries in the states, Puerto Rico and U.S. Virgin Islands, and 48 people have…
Headline
A new Centers for Disease Control and Prevention study published today in JAMA Pediatrics reveals that nearly one in five adolescents aged 12-18 years, and one…
Headline
The Centers for Disease Control and Prevention today released updated guidance to help health care providers diagnose and treat patients with vaping-associated…
Headline
The CDC yesterday updated the number of people with confirmed or probable lung injuries associated with electronic cigarette use or vaping products to 2,172 in…
Headline
A record low 13.7% of U.S. adults smoked cigarettes in 2018, down from 14% in 2017.
Headline
The Centers for Disease Control and Prevention today identified vitamin E acetate as a “potential chemical of concern” in biologic samples from patients with…